ArticleJournal of animal science2026
Can antioxidants' supplementation modulate the impact of dietary deoxynivalenol and zearalenone co-contamination on the systemic and mucosal immune response of weaned pigs?
Article in Journal of animal science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
This study aimed to determine the effects of deoxynivalenol (DON) and zearalenone (ZEA) co-contamination on systemic immune responses and intestinal mucosal immunity in weaned piglets and to evaluate the mitigating ability of antioxidant supplements such as vitamins, organic selenium, and quercetin. Seventy-two castrated male pigs aged 20 d were randomly assigned to 12 pens (two animals per pen) and fed diets containing DON and ZEA at 0.8 and 0.06 mg/kg, respectively (CTR), or at 2.8 ± 0.3 and 1.20 ± 0.4 mg/kg, respectively (MT), or the MT diet supplemented with: vitamins A, C, and E (MT+V); yeast enriched with glutathione (GSH) and Se (MT+Y); quercetin (MT+Q); the combination of the 3 previous supplements (MT+VYQ). Pigs were immunized against ovalbumin (OVA) on d 0 and 7; blood samples were then collected on d 7 and 14 to measure cytokines, haptoglobin, and anti-OVA antibodies and to evaluate the leukocyte profile and phagocytic activity. The co-occurrence of DON and ZEA in the diet reduced the proportions of T helper lymphocytes and monocytes/macrophages but increased natural killer cells (P < 0.05). The MT+Y treatment increased γδ T lymphocytes (P < 0.05) and tended to decrease CD4+ CD8+ lymphocytes (P = 0.074). The MT+Q diet increased γδ T lymphocytes (P < 0.05) and tended to lower cytotoxic T lymphocytes (P = 0.086). Furthermore, the MT+Y treatment also increased interleukin (IL) 1β plasma concentration on d 7 and decreased it on d 14 (time × treatment effect, P < 0.001), whereas the MT+Q diet decreased IL1β and increased IL10 concentrations on d 7 (time × treatment effect, P < 0.001). The MT+Y diet also increased IL10 (P < 0.05) and tended to increase C-X-C motif chemokine ligand 10 (CXCL10) expressions in the ileum (P < 0.05 and P = 0.066, respectively). The MT+Q treatment increased B-cell lymphoma 2 (BCL2) and tended to increase IL10 expressions in the jejunum (P < 0.05 and P = 0.072, respectively). Diets containing DON and ZEA thus modified the blood leukocyte profile in weanling pigs. Providing antioxidant supplements did not restore the normal profiles. However, Se+GSH and quercetin did modify several immune parameters. The effect of the M+VYQ combination was no greater, and possibly weaker, than the single dietary supplements.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.